C07C 251/44
With the carbon atom of at least one of the oxyimino groups
Official title: with the carbon atom of at least one of the oxyimino groups being part of a ring other than a six-membered aromatic ring
C07C251/44 (With the carbon atom of at least one of the oxyimino groups) appears on 158 US grants and 123 published applications in this corpus.
Search patents in C07C- Granted patents
- 158
- Published applications
- 123
- Assignees
- 115
- Inventors
- 554
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 2 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 9 | 0 |
| 1999 | 8 | 0 |
| 2000 | 11 | 0 |
| 2001 | 12 | 1 |
| 2002 | 8 | 7 |
| 2003 | 3 | 5 |
| 2004 | 5 | 8 |
| 2005 | 4 | 2 |
| 2006 | 3 | 6 |
| 2007 | 2 | 4 |
| 2008 | 5 | 5 |
| 2009 | 3 | 7 |
| 2010 | 3 | 7 |
| 2011 | 6 | 6 |
| 2012 | 3 | 7 |
| 2013 | 4 | 6 |
| 2014 | 4 | 6 |
| 2015 | 8 | 6 |
| 2016 | 8 | 10 |
| 2017 | 6 | 10 |
| 2018 | 5 | 3 |
| 2019 | 4 | 2 |
| 2020 | 2 | 5 |
| 2021 | 2 | 1 |
| 2022 | 1 | 2 |
| 2023 | 1 | 2 |
| 2024 | 1 | 2 |
| 2025 | 1 | 3 |
| 2026 | 3 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions and methods of making expanded hematopoietic stem cells using derivatives of fluorene4 Aug 2026US 12,698,255 B2ImmuneBridge Inc.
- Substrate treating method16 Jun 2026US 12,660,547 B2SCREEN Holdings Co., Ltd.
- 4-membered ring carboxamides used as nematicides6 Jan 2026US RE50,724 E1Syngenta Crop Protection AG
- Fungicidal compounds1 Apr 2025US 12,262,710 B2Syngenta Crop Protection AG
- Isomer-enriched 3-caranlactams and polyamides based thereon with high optical purity and adjustable crystallinity for high-performance applications26 Nov 2024US 12,152,107 B2Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V.
- 2,6-dibenzylidenecyclohexanone oxime compound and preparation method therefor and use thereof20 Nov 2025US 2025/0353812 A1Wenzhou Medical University
- Fungicidal compounds31 Jul 2025US 2025/0241304 A1Syngenta Crop Protection AG
- Fragrance and flavor materials20 Mar 2025US 2025/0091984 A1Takasago International Corporation
- Indanone and tetraloneketo or hydroxyl oximes as cancel therapeutics25 Jul 2024US 2024/0246903 A1Board of Regents, The University of Texas System
- Substrate treating method16 May 2024US 2024/0162033 A1SCREEN Holdings Co., Ltd.
Most cited
By later US patents
- Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity62US 5,723,666 AAllergan, Inc. · 1998
- Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity58US 5,773,594 AAllergan, Inc. · 1998
- Tetrahydronaphthalene derivatives substituted in the 8 position with alkyhidene groups having retinoid and/or retinoid antagonist-like biological activity48US 5,763,635 AAllergan, Inc. · 1998
- Protein kinase C modulators N48US 6,080,784 AProcyon Pharmaceuticals, Inc. · 2000
- Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity39US 6,555,690 B2Allergan, Inc. · 2003